SCHEMBL6598374

SCHEMBL6598374

C/C=C/Cn1c(N2CCCN(CCC(CN(C)C(=O)c3cc(-n4cnnn4)ccc3OC)c3ccc(F)cc3)CC2)nc2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 4/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 3/20 0.33
MAPT P10636 3/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP2D6 P10635 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6598377 1.00 TACR2 (0.34) TACR2KDM4ELMNAMAPTDRD2
SCHEMBL6597082 0.94 MEN1 (0.34) TACR2KDM4ELMNAMAPTDRD2
SCHEMBL6597091 0.92 TACR2 (0.44) TACR2
SCHEMBL6597085 0.92 TACR2 (0.44) TACR2
SCHEMBL6594885 0.92 HRH1 (0.41) TACR2CYP2D6CHRM1HRH1KCNH2
SCHEMBL6596468 0.91 TACR2 (0.34) TACR2KDM4ELMNAMAPTDRD2
SCHEMBL6593690 0.91 DRD2 (0.36) TACR2DRD2DRD4DRD3SMN1; SMN2
SCHEMBL6598208 0.91 CHRM1 (0.37) TACR2CHRM1HRH1KCNH2
SCHEMBL6598788 0.90 TACR2 (0.34) TACR2KDM4ELMNAMAPTDRD2
SCHEMBL6597713 0.89 CHRM1 (0.33) TACR2CHRM1HRH1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888338-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2004-11-17 EP disclosed
EP-0888338-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1999-01-07 EP disclosed
WO-1997030991-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1997-08-28 WO disclosed